NMUH Staff side and Joint LNC Meeting 13th October

Items of interest from UCL Partners

Speech by Andrew Rowlands at UEMS

Upcoming meetings for JF

Elections from the UK-CC of specialty reps, to subcommittees and other committees



The staff side LNC took place on 13th October (these are not minutes)

Those present included Sunil Trakru (Chair) John Firth (Deputy Chair), Penny Hyatt (MSC Chair) , Hawa Petkar (Cons Microbiologist ) Piyusha Kapila, ( Cons Paediatrics) Devesh Sharma (A&E Consultant) Gopakumar Sudhir (Cons. Anaesthetist)  Mohammed Anwar  (AS Orthopaedics) Yai Yoong (Cons. Gynaecologist) and Rosemary Stanley McKenzie (BMA Industrial Relations Officer Officer)

The following discussions took place

  • Attracting new members to the staff side local negotiating committee and ways of informing the medical staff of the function and discussions of the staff and joint LNC
  • A new CEA policy has been received but not yet agreed
  • The Tariff for Educational Supervisors has been accepted to remain as 0.25 SPA per trainee .
  • Upcoming running of NMUH Dermatology to be transferred Whittington Health in January 2017 as mentioned at the previous Medical Staff Committee. The two week cancer waiting time refferals will automatically go to the Whittington Hospital.
  • Regarding Junior Doctors issues it was noted Guardian of safe working is Drev Rastagi
  • There was a brief outline of the state of the Consultant Contract negotiations
  • Other documents still under discussion , Acting Down Policy m Leave policies.



The jLNC meeting followed on from the staff side meeting.The following are some of the items discussed. (NB these are not minutes but based on notes by JF)

  • Report by management on the visit to NMH of the Care Quality Commision whose finding will take several months to be published.
  • The imminent temporary transfer of all NMUH endoscopy to Chase Farm in a matter of weeks was discussed to allow for refurbishment as was the transfer of the running of NMUH Dermatology to Whittington Health.
  • Junior Dr’s Contract implementation timetable given by management
  • Further information regarding the appointment of the Guardian of Safe Working
  • Establishment of not only of a Junior Dr Forum at NMH but also “Trust Doctor “ forum will occur, as the latter are not part of the JDr Contract and have different Terms and Conditions of Service.
  • An equality assessment has been done by NMUH on the new JDr contract
  • A “Champion for Medical Education” has been appointed.
  • The method of reporting Exceptional Events has been introduced in the Trust, additional training for Educational supervisors which will start in November.
  • A new Car Parking policy would be submitted to the next joint LNC and Joint Staff Committee. In the meantime the current parking permits will remain. Medical staffing will review any car parking fines (with the exception of not showing you parking permit) – contact HR.

The next joint LNC meeting is on December 15th


Items of interest

UCL Partners

News 13 October 2016

Innovation fellows inspire national programme to adopt novel solutions to improve patient care

News 11 October 2016

How to Guide on developing NHS youth forums published

Partnership Press September Issue[UNIQID]



The following speech was given to UEMS Council on Saturday 22 October 2016 by Dr Andrew Rowland. He is the UK-CC’s representative on UEMS and a member of the International Committee. The BMA is a full member of UEMS. For full details of UEMS can be found at.


Colleagues, this is a speech I never expected to have to give; this is a speech that fills me with trepidation as I look to the political future in Europe; this is a speech that I hope will give a clear demonstration of the BMA’s commitment to UEMS family no matter what that political future may hold.Following the outcome of the UK referendum of 23 June to leave the European Union, there has been considerable speculation about the timing and nature of the UK’s exit from the EU.

The Prime Minister has announced that the UK will trigger Article 50 of the Lisbon Treaty by the end of March 2017. This means that the UK looks set to leave the European Union by the summer of 2019, as Article 50 gives a two year period during which the UK’s exit has to be negotiated with the remaining 27 members of the EU and ultimately approved by them.

The Prime Minister has said that the UK will be a fully independent, Sovereign country; free to make its own decisions on a whole range of different issues such as how the UK will choose to control immigration and still being able to trade freely with Europe. The Prime Minister said that she wants a mature, cooperative relationship with European Partners and that this will require give and take. She has underlined that the UK and its European neighbours face similar challenges and if the negotiations are approached in a constructive manner this should support a smooth departure from the EU and opportunities not problems. The Prime Minister has also announced that the government will introduce a Great Repeal Bill which will end the authority of EU law in the UK, removing the role of the European Court of Justice. This will be undertaken, we understand, in conjunction with the conversion of the existing body of EU legislation into UK law which, subject to international agreements and treaties, the UK parliament will be able to repeal or amend.

Once the UK tells the EU that it is withdrawing under Article 50, we understand it will not be able to participate in the European Council or in decisions concerning it. So, after Article 50 is triggered, the UK will carry on taking part in other EU business as normal, but it won’t participate in internal discussions or decisions about its own withdrawal. The UK’s impending departure from the EU, especially given its government’s stated objective that the UK “will decide for ourselves how we control immigration” will have profound repercussions for the British medical profession and the European medical profession and their mutual ongoing abilities to provide high quality healthcare across the continent. Whilst “Brexit” will fundamentally alter both the UK and the EU, it must not be permitted to threaten Europe’s health.

Europe’s medical workforces have become increasingly integrated and interdependent – over 30,000 registered doctors in the UK gained their primary qualification in another European Economic Area state – with such free movement playing a crucial role in both doctors’ professional development and in meeting varying medical workforce requirements across Europe.

“Brexit” may slow, but will not reverse, such pan-European professional migration. Nor must it be allowed to threaten the progress of attendant patient safety measures like the alert mechanism – an early warning system which advises all European regulators when a doctor is banned from practise or their ability to practice restricted – or ongoing efforts to ensure that minimum standards in medical education and training are met.

Comparable levels of pan-European professional migration also exist in the medical research and innovation sector with 15% of all academic staff at UK universities originating from other EU member states. The importance of pan-European collaboration to this sector is axiomatic.

With medical research becoming increasingly international in focus and integral to tackling the main current and future societal challenges, it is imperative that solutions are found to secure researcher mobility and the provision of clear long-term frameworks in a post-Brexit EU. Likewise, and as public health threats such as those arising from antimicrobial resistance do not respect borders, the UK’s withdrawal from the EU must not be permitted to impinge on international cross-sectional and inter-organisational collaboration and coordination.

Colleagues, noone at UEMS Council knows what will happen before March 2017; noone at UEMS Council knows what will happen during the two years of negotiations until the Spring of 2019; absolutely no one at UEMS Council knows exactly what the future will look like without the UK in the EU. The UK finds it valuable to be a full member of the UEMS Board and Council and I hope that UEMS finds our involvement here valuable too.

The principle of medical neutrality in times of conflict is a guiding principle of our civilisation. We cannot allow Brexit to damage the relationships between members of the UEMS family. Whilst, of course, the “Brexit” negotiations will be carried out between our respective governments, not people in this room, and between long-standing allies, we believe that the same principle should be applied here to the medical profession in order to ensure that the UK’s withdrawal from the EU does not result in any collateral damage to our patients’ health. I hope that other National Member Associations and European Medical Organisations will recognise the huge amount of work that lies ahead and that they will be prepared to join with us in writing to Ministers and EU leaders to urge caution in the negotiations to protect from unintended and collateral adverse consequences to the medical profession and patients’ health.

Colleagues, we live now in difficult times; we live now in unprecedented times; we live now in extra-ordinary times with many traps, dangers and hurdles ahead.

But whatever happens politically; whatever happens in the media; and whatever happens to public opinions I’m stating very clearly, today, before UEMS Council, that that the UK delegation re-affirms our commitment to working with our European Partners to safeguard the future of the European Medical Profession and the patients it serves.

Mr President, Mr Secretary General, thank you very much




I was re-elected for a second term to the International Committee by UK-CC on 21/10/16 , unfortunately two days after their first meeting of the session. Hopefully I will get some feedback in due course.


26TH October will be my first attendance of the FMC which I have joined because of my interest in the position of Medical Examiner in Cause of Death , that is being introduces in April 2018,  though the committee has a much wider remit.

I have also been elected to the Professional Fees Committee from UK-CC though their first meeting is not until November 24th.

Other News

A group of 2nd year UCL Medical Students will be attending NMUH for eight consecutive Friday afternoons  from 28th October. This is a Student Selective Component of their course entitled “Surgical Pathology in Practice” which I have organised for several years. This time 17 students are attending which is a record of sorts. My thanks to the Post Mortem room staff where most of the teaching will take place and the Library where the students will be doing some self directed learning.

This brings in an extra £5k of “SIFT money” some of which I hope can be used for the pathology “museum specimens”


Elections from the UK-CC of specialty reps, to subcommittees and other committees

Policy based subcommittees

Healthcare policy subcommittee

  • Anil Jain
  • Gary Wannan
  • Simon Walsh

Development, communications and professionalism subcommittee

  • Sara Hedderwick
  • Nick Flatt
  • Helen Fidler

Specialty leads

Anaesthetics – Peter Maguire

Dermatology and venereology – Els Draeger

Emergency medicine – Simon Walsh

Medical specialties – Vishal Sharma

Obstetrics and gynaecology – vacant

Orthopaedics – Daniel Redfern

Paediatrics – Selwyn D’Costa

Pathology – Anne Thorpe

Psychiatry – Andrew Molodynski

Radiology – Anne Carson

Surgical specialties – Maharukh Daruwalla

Other committees

Committee for community care – Anil Jain

Committee for medical managers (observer) – Stephen Austin

European forum – Shree Datta

GMC working party – Indeewar Kapila

International committee – John Firth

Pensions committee – Derek Machin

Professional fees committee – John Firth

Private practice committee – Mike Henley and Indeewar Kapila

SASC – Derek Machin

Conference agenda committee    – Derek Machin